The hypolipidaemic effect of EPA is potentiated by 2- and 3-methylation.

Adv Exp Med Biol

Department of Clinical Biochemistry, University of Bergen, Haukeland Hospital, Norway.

Published: April 2000

Download full-text PDF

Source
http://dx.doi.org/10.1007/0-306-46818-2_26DOI Listing

Publication Analysis

Top Keywords

hypolipidaemic epa
4
epa potentiated
4
potentiated 3-methylation
4
hypolipidaemic
1
potentiated
1
3-methylation
1

Similar Publications

Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia.

Int J Cardiol

December 2013

IRCCS MultiMedica, Milan, Italy; Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy. Electronic address:

Hypertriglyceridaemia (HTG) is an independent risk factor for cardiovascular disease; high-risk patients with HTG, such as those with metabolic syndrome or diabetes, may benefit from hypolipidaemic therapies. Several lipid-lowering drugs act by reducing triglyceride (TG) levels, including fibrates, nicotinic acid and omega-3 fatty acids. The omega-3 polyunsaturated fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) dose-dependently reduce plasma TG levels; the effect tends to be greater in patients with higher TG levels at baseline.

View Article and Find Full Text PDF

Adipose tissue has a key role in the development of metabolic syndrome (MS), which includes obesity, type 2 diabetes, dyslipidaemia, hypertension and other disorders. Systemic insulin resistance represents a major factor contributing to the development of MS in obesity. The resistance is precipitated by impaired adipose tissue glucose and lipid metabolism, linked to a low-grade inflammation of adipose tissue and secretion of pro-inflammatory adipokines.

View Article and Find Full Text PDF

Aims/hypothesis: Fatty acids of marine origin, i.e. docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) act as hypolipidaemics, but they do not improve glycaemic control in obese and diabetic patients.

View Article and Find Full Text PDF

Hypolipidaemic effects of fenofibrate and fasting in the herbivorous grass carp ( Ctenopharyngodon idella) fed a high-fat diet.

Br J Nutr

December 2008

Institute of Aquatic Economic Animals, School of Life Sciences, Sun Yat-sen University, 135 Xin'gang Xi Road, 510275 Guangzhou, China.

We investigated whether the hypolipidaemic effect of fenofibrate and fasting observed in most omnivorous mammals may also apply to herbivorous fish. Grass carp (Ctenopharyngodon idella) fed a high-fat (8 %) diet exhibited a marked increase in blood lipids and body fat after 6 weeks. They were then treated with fenofibrate (100 mg/kg body weight) in the same high-fat diet for 2 weeks, followed by fasting for 1 week.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!